Bogen Biotechnology a chromatography resin producer was firstly founded in 2013, being professional on developing, manufacturing and application of novel rigid polymeric chromatography resins. The patented Bogen's resins are featured by fully hydrophilic surface, super high ligand densities, and precisely controlled bead and pore size distributions. Bogen support local and international clients on the purification of antibodies, recombinant proteins, vaccines/VLPs and genetic vectors/viral vectors at various phases, from early R&D to commercialized production. Affinity resins, ion exchange, hydrophobic interaction and pre-activated resins are all included in Bogen's product catalogue. Custom resin designed to meet clients’ unique purification requirements is Bogen's special service in the China local market.
